drugset / Trial / NCT01908400
Safety and Efficacy of BMMNCin Patients With Mental Retardation
NaSingle-groupOpen-labelTreatment
Summary
Mental retardation is a condition diagnosed before age 18 that includes below-average general intellectual function, and a lack of the skills necessary for daily living. Mental retardation affects about 1 - 3% of the population. There are many causes of mental retardation, but find a specific reason in only 25% of cases.Bone marrow derived stem cells are used in this condition to prove its safety and efficacy .
Timeline
- Start
- 2014-09
- Primary completion
- 2016-11
- Completion
- 2016-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BMMNCs | Cell therapy | — | Intravenous |
Indications
No indication recorded.